Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03070938 · ClinicalTrials.gov registry record
PuraPly™ Antimicrobial Wound Matrix and Wound Management
A clinical trial of Surgical Wound and Venous Ulcer, sponsored by Organogenesis.
- Completed
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT03070938: Completed study of Surgical Wound and Venous Ulcer, sponsored by Organogenesis.
NCT03070938 is a study of Surgical Wound and Venous Ulcer that has completed, run by Organogenesis. The registered enrollment target is 100 participants, above the 90-participant average among 17 other Surgical Wound trials with a reported enrollment target (11% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03070938, a study of Surgical Wound and Venous Ulcer, has completed, sponsored by Organogenesis.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The PuraPly Antimicrobial Wound Matrix (PuraPly AM) case series is a prospective, observational study for patients who have received PuraPly AM which consists of a collagen sheet coated with polyhexamethylenbiguanide hydrochloride (PHMB) and is intended for the management of wounds; no experimental intervention is involved.
Primary Outcome
As measured from change in status from baseline
Conditions Studied
Interventions
- DEVICE PuraPly™ Antimicrobial Wound Matrix
Study Locations (1)
New York
- Winthrop University Hospital - Mineola
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2016-11 |
| Est. Completion | 2017-10 |
What the finished NCT03070938 record still lists
NCT03070938 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 90-participant average among 17 other Surgical Wound trials with a reported enrollment target (11% higher).
The record links to 5 conditions, with Surgical Wound appearing as the primary indexed condition, and to 1 intervention - of which PuraPly™ Antimicrobial Wound Matrix is the first listed.
NCT03070938 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03070938 about?
NCT03070938 is a clinical study titled "PuraPly™ Antimicrobial Wound Matrix and Wound Management". The PuraPly Antimicrobial Wound Matrix (PuraPly AM) case series is a prospective, observational study for patients who have received PuraPly AM which consists of a collagen sheet coated with polyhexamethylenbiguanide hydrochloride (PHMB) and is intended for the management of wounds; no experimental ...
What is the current status of trial NCT03070938?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2016-11. Estimated completion is 2017-10.
What conditions does trial NCT03070938 study?
This clinical trial studies the following conditions: Surgical Wound, Venous Ulcer, Pressure Ulcer, Trauma Wound, Diabetic Ulcer.
What interventions are being tested in trial NCT03070938?
The interventions under investigation include: PuraPly™ Antimicrobial Wound Matrix (DEVICE).
Who is sponsoring clinical trial NCT03070938?
This trial is sponsored by Organogenesis, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03070938 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgical Wound
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03070938's enrollment target sits among peer trials
100 5th of 17 higher than 13 of 17 other Surgical Wound trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Surgical Wound trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Zinc Oxide Versus Petrolatum Following Skin Surgery
RECRUITING · Early Phase 1
-
Evaluating rhPDGF-BB-Enhanced Wound Matrix for Head and Neck Reconstruction
RECRUITING · Phase 2
-
Early Versus Delayed Bathing of Orthopaedic Surgical Wounds
RECRUITING · NA
-
A Prospective, Single-arm, Clinical Trial of Electrospun Fiber Matrix (Restrata) in the Treatment of Surgical Defects Secondary to Resection of Malignant Cutaneous Neoplasms
RECRUITING
-
fMRI and IVCM Cornea Microscopy of CXL in Keratoconus
RECRUITING
-
Regenn® Therapy System Safety Study
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia